Prevention in Belgian Hockey : What Does the Staff Really Put in Place?

• Sponsor: University of Liege (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04977154
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Anticipated Duration (Months): 12
• Patients Per Site Per Month: 5

Study Details

Study Description

Brief Summary

Purpose: To provide an update on the implementation of prevention among hockey players by their entourage.

Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of trainers.

The questionnaire will be validated by experts and published on an online survey website

Condition or Disease	Intervention/Treatment	Phase
Primary Prevention; Questionnaire and Survey; Hockey Player	Other: Primary prevention

Study Design

• Study Type: Observational
• Anticipated Enrollment: 60 participants
• Observational Model: Cohort
• Time Perspective: Other
• Official Title: Prevention in Belgian Hockey : What Does the Staff Really Put in Place?
• Actual Study Start Date: Jul 1, 2021
• Anticipated Primary Completion Date: Jun 1, 2022
• Anticipated Study Completion Date: Jul 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Trainers	Other: Primary prevention; The primary prevention that the trainers put in place for the hockey players

Outcome Measures

Primary Outcome Measures

1. Primary prevention by a questionnaire [Time Frame: The questionnaire will last 15 minutes at most]

   The trainers will respond to a questionnaire that will inform us about the primary prevention that they put in place in hockey.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Professions: hockey trainer

Exclusion Criteria:

• /

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Liège	Liège		Belgium	4000

Sponsors and Collaborators

• University of Liege

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Gofflot Amandine, Principal Investigator, University of Liege
• ClinicalTrials.gov Identifier: NCT04977154
• Other Study ID Numbers: 160521
• First Posted: Jul 26, 2021
• Last Update Posted: Jul 26, 2021
• Last Verified: Jul 1, 2021

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Jul 26, 2021